|
|
| | 2-Quinolinamine, N-[(4-chlorophenyl)methyl]-4-[4-[(1,1-dimethylethyl)amino]-1-piperidinyl]-, hydrochloride (1:1) Basic information |
| | 2-Quinolinamine, N-[(4-chlorophenyl)methyl]-4-[4-[(1,1-dimethylethyl)amino]-1-piperidinyl]-, hydrochloride (1:1) Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO : 8.33 mg/mL (18.13 mM; ultrasonic and warming and heat to 60°C) | | form | Solid | | color | Off-white to light yellow |
| | 2-Quinolinamine, N-[(4-chlorophenyl)methyl]-4-[4-[(1,1-dimethylethyl)amino]-1-piperidinyl]-, hydrochloride (1:1) Usage And Synthesis |
| Uses | Ezurpimtrostat hydrochloride (compound 2-3) is a potent and orally active anti-fibrotic agent. Ezurpimtrostat hydrochloride reduces significantly the liver fibrosis in DEN (diethyl nitrosamine) cirrhotic rat model. Ezurpimtrostat hydrochloride can be used for the research of fibrosis, cancer, autophagy and cathepsins B (CTSB), L (CTSL) and D (CTSD) related diseases [1]. | | in vivo | Ezurpimtrostat hydrochloride (compound 2-3) (15 mg/kg/day, PO, for 6 weeks) significantly reduces the area of liver fibrosis and the level of collagen fibers deposition (by 41.0%) in DEN cirrhotic rat model[1]. | | References | [1] Philippe Halfon, et al. Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins b (ctsb), l (ctsl) and d (ctsd) related diseases. EP3620164A1. |
| | 2-Quinolinamine, N-[(4-chlorophenyl)methyl]-4-[4-[(1,1-dimethylethyl)amino]-1-piperidinyl]-, hydrochloride (1:1) Preparation Products And Raw materials |
|